Plectranthus Amboinicus Extract for Rheumatoid Arthritis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for rheumatoid arthritis, such as NSAIDs, steroids, and immunosuppressive agents, often cause significant side effects and are inconvenient, highlighting the need for a safer and more effective therapeutic option.
Innovation Solution
The use of crude extracts or extracts from Plectranthus Amboinicus (PA) as a pharmaceutical composition for treating rheumatoid arthritis, administered orally, which has been shown to inhibit inflammation and reduce arthritic symptoms in animal models.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If NSAIDs or steroids are used to treat rheumatoid arthritis, then anti-inflammatory effect is improved, but side effects such as bowel tract abnormalities and bleeding worsen
Solution Approach 1:
The patent uses a natural herb (Plectranthus Amboinicus) as a disposable, renewable resource替代 harmful pharmaceuticals. The herb can be cultivated continuously and provides therapeutic effects without the cumulative toxicity of NSAIDs and steroids, resolving the contradiction between effective anti-inflammatory treatment and harmful side effects
Solution Approach 2:
The patent introduces Plectranthus Amboinicus as an intermediary substance between the patient and the disease process. This natural mediator provides anti-inflammatory and immunosuppressive effects through its active compounds (rosmarinic acid, carnosic acid) without directly causing the harmful effects associated with conventional drugs, thus resolving the technical contradiction
2Reliability
If TNF-α protein antagonist is used to palliate conditions rapidly, then treatment efficacy is improved, but convenience worsens due to invasive administration mode
Solution Approach 1:
The patent replaces the mechanical/invasive administration method (injections) with a natural, orally administrable herb. Plectranthus Amboinicus delivers comparable therapeutic effects through natural absorption pathways, eliminating the need for invasive procedures while maintaining treatment efficacy, thus resolving the contradiction between rapid effective treatment and convenience
3Reliability
If Radix Tripterygii Wilfordii is used for treating rheumatoid arthritis, then anti-inflammatory and pain relief effects are improved, but safety worsens due to toxic side effects
Solution Approach 1:
The patent changes the chemical composition parameters by using Plectranthus Amboinicus, which contains different active compounds (rosmarinic acid, carnosic acid, borneol) with lower toxicity profiles. This parameter change maintains anti-inflammatory efficacy while significantly reducing toxic side effects compared to Radix Tripterygii Wilfordii, resolving the technical contradiction
Data Source
AI summary
A pharmaceutical composition comprising a crude extract or extract of Plectranthus Amboinicus (Lour.) Spreng (PA) for the treatment of rheumatoid arthritis is described. The use of the crude extract or extract of Plectranthus Amboinicus (Lour.) Spreng for the manufacture of medicaments for treating rheumatoid arthritis is also described.